Joining us for today's presentation are the company's CEO, Thomas Stepien, and CFO, Ricardo Rodriguez. Please note that this presentation contains forward-looking statements, including, but not ...

KOMZIFTI™ (ziftomenib) launch generating early revenue momentum and rapid payer coverage decisions – – Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, su ...

About Peyto Exploration & Development Corp. Peyto Exploration & Development Corp. engages in the exploration, development, and production of oil and natural gas. Its operations include deep basin, ...

A growing body of research is proving that the often discarded portions of an animal are actually the most nutrient dense.

Zebra finch 'heat song' changes hatchling development “珍珠鸟”高温时的鸣叫有助于雏鸟生长 Episode 160819 / 19 Aug 2016 A study has found that ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK ...

Successfully started 216 patients on IBTROZI® (taletrectinib) in the fourth quarter of 2025, for a total of 432 new patient starts since launch in the second half of ...

Topline data of investigator-initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% complete response ...